82478 - Skin Pathology Evaluation Program
- : Online
The Skin Pathology Evaluation Program enables general
practitioners who refer skin pathology to Australian
Clinical Labs to submit their provisional diagnosis on
cases in which histological evaluation is needed.
Monthly reports will then be delivered online to all participants, highlighting performances against those of your peers, in contrast to the state and national benchmarks, while maintaining confidentiality to all clinicians.
The report includes downloadable charts to assist participants attain a positive performance in the program.
To successfully qualify for CPD points, participants will maintain registration in the program for 2 intervals (6 months per interval) and submit a minimum of 20 excision samples per interval.
Approximately, two in three Australians will be diagnosed with skin cancer by the time they are 70, with more than 750,000 people treated for one or more non-melanoma skin cancers in Australia each year.
Excluding non-melanoma skin cancer, melanoma is the third most common cancer in Australian women and the fourth most common cancer in men, and the most common cancer in Australians aged 15-44 years. In 2012, 12,036 Australians were diagnosed with melanoma.
Every year, in Australia:
•skin cancers account for around 80% of all newly diagnosed cancers
•between 95 and 99% of skin cancers are caused by exposure to the sun
•GPs have over 1 million patient consultations per year for skin cancer
•the incidence of skin cancer is one of the highest in the world, two to three times the rates in Canada, the US and the UK.
REF: http://www.cancer.org.au/about-cancer/types-of-cancer/skin-cancer.html (last updated on: Monday, December 12, 2016)